Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges

Area of Science:

• Regenerative Medicine
• Hepatology
• Immunology

Background:

• Chronic liver diseases are a global health concern requiring new treatments beyond transplantation.
• Cell-based therapies offer potential for liver function restoration via tissue repair and immunomodulation.
• Mesenchymal stem cells (MSCs) are a primary focus for these therapeutic strategies.

Purpose of the Study:

• To review current advancements in cell therapies for chronic liver diseases.
• To analyze challenges and critical issues associated with cell therapy applications.
• To specifically discuss mesenchymal stem cells (MSCs) in liver disease treatment.

Main Methods:

• Review of clinical trials and preclinical animal studies on cell therapies for liver diseases.
• Analysis of existing literature on therapeutic efficacy and safety.
• Focused examination of mesenchymal stem cell (MSC) parameters.

Main Results:

• Cell therapies demonstrate potential in improving chronic liver conditions.
• Various cell types are under investigation in clinical and preclinical settings.
• Mesenchymal stem cells (MSCs) are extensively studied but require optimization.

Conclusions:

• Cell-based therapies, particularly MSCs, represent a promising avenue for treating chronic liver diseases.
• Further research is needed to address challenges in dosage, administration, and pharmacokinetics/pharmacodynamics (PK/PD) of MSCs.
• Optimizing MSC therapy is crucial for successful clinical translation in liver disease management.